Hbk Investments L P Biomarin Pharmaceutical Inc Transaction History

Hbk Investments L P

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $1.19 Million - $1.51 Million	-17,700 Reduced 48.23%	19,000 $1.28 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $2.95 Million - $3.45 Million	36,700 New	36,700 $3.14 Million

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.